Martina C. Cornel researcher ORCID ID = 0000-0002-5397-5544
Cornel, Martina C.
Cornel, Martina C. 1959-
Cornel, M.C. (Martina Cornelia), 1959-
Cornel, M. C., 1959-
VIAF ID: 306176304 (Personal)
Permalink: http://viaf.org/viaf/306176304
Preferred Forms
-
-
-
- 100 1 _ ‡a Cornel, Martina C.
- 100 1 _ ‡a Cornel, Martina C. ‡d 1959-
- 100 1 _ ‡a Cornel, Martina C. ‡d 1959-
- 100 0 _ ‡a Martina C. Cornel ‡c researcher ORCID ID = 0000-0002-5397-5544
4xx's: Alternate Name Forms (8)
5xx's: Related Names (4)
- 510 2 _ ‡a Klinische genetica en antropogenetica
- 510 2 _ ‡a Medische Genetica-vakgroep
- 510 2 _ ‡a Vrije Universiteit
- 510 2 _ ‡a Vrije Universiteit ‡9 g:Amsterdam ‡e Affiliation
Works
Title | Sources |
---|---|
Community genetics: van vermenigvuldigen en delen | |
Cornel, Martina: Prevention of congenital anomalies | |
The Dutch national summit on preconception care: a summary of definitions, evidence and recommendations | |
Ephedrine treatment for autoimmune myasthenia gravis | |
The ethics of clinical applications of germline genome modification: a systematic review of reasons | |
European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death | |
Evaluation of population newborn screening practices for rare disorders in member states of the European Union. | |
The expansion of newborn screening: is reproductive benefit an appropriate pursuit? | |
Family communication as strategy in diabetes prevention: an observational study in families with Dutch and Surinamese South-Asian ancestry | |
A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document | |
From rationing to rationality: an n-of-one trial service for off-label medicines for rare (neuromuscular) diseases. | |
GenEthics and religion: Editors: Georg Pfleiderer, Gabriella Brahier, Basel, Switzerland; Klaus Lindpaintner, Newark, USA. 154 pages, hard cover, 2010, Karger, Basel, Switzerland. ISBN 978 3 8055 8973 4. | |
Genetic educational needs and the role of genetics in primary care: a focus group study with multiple perspectives | |
Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing | |
Genetic screening and democracy: lessons from debating genetic screening criteria in the Netherlands | |
Genetic testing and common disorders in a public health framework | |
Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations | |
Genetica | |
Genome-wide sequencing in acutely ill infants: genomic medicine's critical application? | |
Genomic newborn screening: public health policy considerations and recommendations | |
Genomics for all in the 21st century? | |
Governing biological material at the intersection of care and research: the use of dried blood spots for biobanking | |
How will new genetic technologies, such as gene editing, change reproductive decision-making? Views of high-risk couples | |
Illness representations of type 2 diabetes patients are associated with perceptions of diabetes threat in relatives | |
Implementing genetic education in primary care: the Gen-Equip programme | |
Improving test properties for neonatal cystic fibrosis screening in the Netherlands before the nationwide start by May 1st 2011 | |
Information should be given on consanguinity as a risk factor for congenital malformations | |
The interface between medically assisted reproduction and genetics: technical, social, ethical and legal issues* | |
Is there an association between maternal carbamazepine use during pregnancy and eye malformations in the child? | |
Italian appeal court: a genetic predisposition to commit murder? | |
Key Implications of Data Sharing in Pediatric Genomics | |
Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment: a focus group study | |
Looking beneath the surface, 2013: | |
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing | |
Mothers' Views on Longer Storage of Neonatal Dried Blood Spots for Specific Secondary Uses | |
Moving towards a cure in genetics: what is needed to bring somatic gene therapy to the clinic? | |
Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide | |
Newborn screening for pompe disease? a qualitative study exploring professional views | |
Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance | |
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Summary and recommendations | |
Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013. | |
Outcomes of pregnancies diagnosed with Klinefelter syndrome: the possible influence of health professionals† | |
Policy Making in Newborn Screening Needs a Structured and Transparent Approach | |
The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study | |
Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population. | |
Preconceptional genetic carrier testing and the commercial offer directly-to-consumers | |
Prevalence of congenital heart disease in patients with phenylketonuria | |
Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands | |
Prioritization of future genetics education for general practitioners: a Delphi study | |
The promises of genomic screening: building a governance infrastructure. Special issue: genetics and democracy | |
Proposed roadmap to stepwise integration of genetics in family medicine and clinical research | |
Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010 | |
Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers | |
Recontacting Pediatric Research Participants for Consent When They Reach the Age of Majority | |
Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics | |
Registratie van aangeboren afwijkingen | |
Renal defects and limb deficiencies in 197 infants: is it possible to define the "acrorenal syndrome"? | |
Reply to Bombard and Mighton | |
Response to letter entitled: Re: Mainstreaming informed consent for genomic sequencing: A call for action | |
A response to the forensic genetics policy initiative’s report “Establishing Best Practice for Forensic DNA Databases” | |
Responsible implementation of expanded carrier screening | |
Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE. | |
Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity | |
Severely impaired health status at diagnosis of Pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening. | |
Some epidemiological data on oral clefts in the northern Netherlands, 1981–1988 | |
Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia | |
Sustained effects of online genetics education: a randomized controlled trial on oncogenetics | |
Towards a European consensus for reporting incidental findings during clinical NGS testing | |
Translational research in genomics of Alzheimer's disease: a review of current practice and future perspectives | |
Trends in genetic patent applications: the commercialization of academic intellectual property | |
The use of birth defect registries for etiological research: a review | |
The use of PROMs and shared decision-making in medical encounters with patients: An opportunity to deliver value-based health care to patients | |
Using web-based familial risk information for diabetes prevention: a randomized controlled trial | |
Validation of self-reported folic acid use in a multiethnic population: results of the Amsterdam Born Children and their Development study | |
What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)? | |
What do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites | |
Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market | |
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics | |
Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes |